Skip to main content
. 2016 Nov 22;2:16042. doi: 10.1038/celldisc.2016.42

Figure 4.

Figure 4

C347K/R mutation transforms full-length GLP-1R into a G-protein biased receptor. (a) Position of C347 in GLP-1R. (b) Expression levels of WT and C347K/R GLP-1R detected by immunoblotting using anti-FLAG antibody for detection and β-actin antibody for normalization. G: glycosylated receptor, N: non-glycosylated receptor. ‘RG’ refers to normlalized glycosylated receptor signal relative to WT (WT set as 1.00); ‘RN’ refers to normlalized non-glycosylated receptor signal relative to WT. ‘RT’ refers to normlalized total receptor signal relative to WT. Expression of β-actin is used for normalization (see the ‘Materials and methods’ section). (c and d) EX4(1–39) dose-response curve for cAMP (c) or arrestin binding signal (d) in WT or C347K or R mutated GLP-1R. C347K/R mutant receptors do not activate arrestin signal. All values are means±s.e.m. of two independent experiments, conducted in triplicate. The activity of the receptor exposed to 1 μm EX4 was set to 100%. *: EC50 unavailable.